PT  - JOURNAL ARTICLE
ED  - ,
TI  - Oxprenolol and practolol: new beta blockers
AID  - 10.1136/dtb.9.1.1
DP  - 1971 Jan 01
TA  - Drug and Therapeutics Bulletin
PG  - 1--3
VI  - 9
IP  - 1
4099  - http://dtb.bmj.com/content/9/1/1.short
4100  - http://dtb.bmj.com/content/9/1/1.full
SO  - Drug Ther Bull1971 Jan 01; 9
AB  - Since the introduction of propranolol (Inderal -ICI) two more β -adrenergic receptor blocking agents have become available for clinical use, practolol (Eraldin - ICI) and oxprenolol (Trasicor - Ciba). Both manufacturers claim that their product is less likely than propranolol to precipitate heart failure or asthma. All three drugs, although structurally similar, have different pharmacological properties which are summarised in the table. The use of the drugs in different clinical situations must therefore be considered separately.